Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.

Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.

Item
http://www.wikidata.org/entity/Q39265240
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignanciesCUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesImmunotherapy strategies for multiple myeloma: the present and the futurep38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.Identification and expression of MMSA-8, and its clinical significance in multiple myeloma.Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.Antibody-based therapeutics for the treatment of human B cell malignanciesImmunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.Dendritic Cell Therapies for Hematologic Malignancies.Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells.First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Mouse models of multiple myeloma: technologic platforms and perspectives.
P2860

Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.

Item
http://www.wikidata.org/entity/Q39265240
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Optimizing dendritic cell vacc ...... promote anti-tumour immunity.
@en
Optimizing dendritic cell vacc ...... promote anti-tumour immunity.
@nl
type
label
Optimizing dendritic cell vacc ...... promote anti-tumour immunity.
@en
Optimizing dendritic cell vacc ...... promote anti-tumour immunity.
@nl
prefLabel
Optimizing dendritic cell vacc ...... promote anti-tumour immunity.
@en
Optimizing dendritic cell vacc ...... promote anti-tumour immunity.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Optimizing dendritic cell vacc ...... promote anti-tumour immunity.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2249.2012.04642.X
P433
P478
P577
P5875
P698
P921
P932